GH EBITDA Growth
Guardant Health Inc · EBITDA Growth
GH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.63%period ending
GH TTM EBITDA YoY % (-7.69% → -11.63%)
Year-over-year change
High-resolution chart · PNG
GH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -11.6314% | |
| -5.4591% | |
| 4.1561% | |
| 24.1743% | |
| 17.1229% | |
| 10.4977% | |
| 9.9662% | |
| -21.0622% | |
| 4.0579% | |
| 33.3838% | |
| 29.5336% | |
| 30.1119% | |
| 7.6772% | |
| -66.5092% | |
| -70.9879% | |
| -46.2148% | |
| -46.0775% | |
| -25.2447% | |
| -59.7802% | |
| -138.5273% | |
| -234.4208% | |
| -354.8264% | |
| -309.7228% | |
| -159.1485% | |
| -45.5326% | |
| 19.6578% | |
| 28.8737% | |
| 9.9541% | |
| 4.5715% | |
| -16.0542% | |
| -7.6921% |